Making medicine is a science and a calling, a calling in which your heart is exercised equally with your head. And when it comes to selling that medicine well, it's difficult to find someone like Habil Khorakiwala, Chairman, Wockhardt, who has been heading one of the largest pharmaceutical and biotechnology majors in India. And if you think that the successes came to Wockhardt just with a magic wand, then look at these facts: Wockhardt's turnover was less than half a million when Habil Khorakiwala took over the reigns of the company in 1966.

Today, Wockhardt is among one of three Indian pharmaceutical companies, which have become global players with a multi disciplinary R&D programme and quality products. With operations in India and UK, Wockhardt today employs more than 4500 people in 9 Plants and 12 Offices worldwide and sells its products in over 35 countries across the globe. Sure, Khorakiwala doesn't need any further introduction. Masters in Pharmaceutical Science from the Purdue University, USA and alumni of the Harvard Business School, the success and glory didn't come to Khorakiwala that easily. To bring Wockhardt to its present top position, Khorakiwala struggled and worked hard for decades before making his and Wockhardt's presence felt in the global arena.

A man known for his vision, dedication and single-mind devotion to work, Khorakiwala has made Wockhardt a leading manufacturer of pharmaceutical formulations, bulk drugs, vaccines, medical nutrition and animal health products. It was Khorakiwala's initiatives that saw the launch of India's first recombinant human insulin, making India the first Asian country to develop, manufacture and market the product. And Khorakiwala's achievements and hard work haven't gone unnoticed, for he has been bestowed with innumerable awards, both national and international.

He has been conferred the prestigious 'Excellence as Top CEO' for the year 2002 by the Institute of Marketing & Management, New Delhi. In 2004, he received the Ernst & Young Entrepreneur of the Year Award in the `Healthcare and Life Sciences' category. He also received the Life Time Achievement Award by the International Medical Integration Council. Khorakiwala's talent is not confined to Wockhardt only, for he has stood the test of social responsibilities equally well. And when it comes to corporate responsibilities, he has been a Non-Official Director on the Board of Directors of Union Bank of India and is a Member of the Board of Governors, Centre for Organisation Development to name a few. It goes without saying that Khorakiwala is the extraordinaire force behind Wockhardt's success in the world of medicines.